These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1879964)

  • 21. Characterization of antibody reactivity to human T-cell lymphotropic virus types I and II using immunoblot and radioimmunoprecipitation assays.
    Hartley TM; Khabbaz RF; Cannon RO; Kaplan JE; Lairmore MD
    J Clin Microbiol; 1990 Apr; 28(4):646-50. PubMed ID: 2185257
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isotypic and IgG subclass restriction of the humoral immune responses to human T-lymphotropic virus type-I.
    Lal RB; Buckner C; Khabbaz RF; Kaplan JE; Reyes G; Hadlock K; Lipka J; Foung SK; Chan L; Coligan JE
    Clin Immunol Immunopathol; 1993 Apr; 67(1):40-9. PubMed ID: 7680300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lack of specificity of HTLV antibody enzyme immunoassays.
    Jang D; Mahony JB; Sellors JW; Galli R; Gregory B; Chernesky MA
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Aug; 9(5):523-4. PubMed ID: 7627628
    [No Abstract]   [Full Text] [Related]  

  • 24. Segregation of human T cell lymphotropic virus type I and II infections by antibody reactivity to unique viral epitopes.
    Lipka JJ; Miyoshi I; Hadlock KG; Reyes GR; Chow TP; Blattner WA; Shaw GM; Hanson CV; Gallo D; Chan L
    J Infect Dis; 1992 Feb; 165(2):268-72. PubMed ID: 1370526
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of immunodominant epitopes of gag and pol gene-encoded proteins of human T-cell lymphotropic virus type I.
    Lal RB; Rudolph DL; Griffis KP; Kitamura K; Honda M; Coligan JE; Folks TM
    J Virol; 1991 Apr; 65(4):1870-6. PubMed ID: 2002547
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Laboratory characterization of human T cell lymphotropic virus types 1 (HTLV-1) and 2 (HTLV-2) infections in blood donors from Sao Paulo, Brazil.
    Segurado AA; Malaque CM; Sumita LM; Pannuti CS; Lal RB
    Am J Trop Med Hyg; 1997 Aug; 57(2):142-8. PubMed ID: 9288805
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neutralizing activity of human antibodies against the structural protein of human T-cell lymphotropic virus type I.
    Inoue Y; Kuroda N; Shiraki H; Sato H; Maeda Y
    Int J Cancer; 1992 Dec; 52(6):877-80. PubMed ID: 1459728
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prototypical HTLV-I/II infection is rare in LGL leukemia.
    Loughran TP; Sherman MP; Ruscetti FW; Frey S; Coyle T; Montagna RA; Jones B; Starkebaum G; Poiesz BJ
    Leuk Res; 1994 Jun; 18(6):423-9. PubMed ID: 8207960
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of four commercial screening assays for the diagnosis of human T-cell lymphotropic virus types 1 and 2.
    Berini CA; Susana Pascuccio M; Bautista CT; Gendler SA; Eirin ME; Rodriguez C; Pando MA; Biglione MM
    J Virol Methods; 2008 Feb; 147(2):322-7. PubMed ID: 17977605
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of a combined lysate/recombinant antigen anti-HTLV-I/II ELISA in high and low endemic areas of HTLV-I/II infection.
    Vrielink H; Sisay Y; Reesink HW; Woerdeman M; Winkel C; de Leeuw SJ; Lelie PN; van der Poel CL
    Transfus Med; 1995 Jun; 5(2):135-7. PubMed ID: 7655577
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of immunoreactive synthetic HTLV-1 peptides in the search for antibody reactivity in multiple sclerosis.
    Lycke J; Andersen O; Svennerholm B; Ben-Menachem E; Horal P; Vahlne A
    Acta Neurol Scand; 1992 Jan; 85(1):44-54. PubMed ID: 1546533
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serological and molecular evidence of infection by human T-cell lymphotropic virus type II in Italian drug addicts by use of synthetic peptides and polymerase chain reaction.
    De Rossi A; Mammano F; Del Mistro A; Chieco-Bianchi L
    Eur J Cancer; 1991; 27(7):835-8. PubMed ID: 1834112
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sensitivity and specificity of a recombinant transmembrane glycoprotein (rgp21)-spiked western immunoblot for serological confirmation of human T-cell lymphotropic virus type I and type II infections.
    Lal RB; Brodine S; Kazura J; Mbidde-Katonga E; Yanagihara R; Roberts C
    J Clin Microbiol; 1992 Feb; 30(2):296-9. PubMed ID: 1347047
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of a chimeric synthetic peptide from the core p19 protein and the envelope gp46 glycoprotein in the immunodiagnosis of HTLV-II virus infection.
    Hernández Marin M; Márquez Bocalandro Y; Vallejo RV; Rodríguez Tanty C; Higginson Clark D; Pozo Peña L; Silva León C
    Prep Biochem Biotechnol; 2003 Feb; 33(1):29-38. PubMed ID: 12693813
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human T lymphotropic virus types I- and II-specific antibody-dependent cellular cytotoxicity: strain specificity and epitope mapping.
    Zhang XQ; Yang L; Ho DD; Kuritzkes DR; Chen IS; Ching WT; Chen YM; Schooley RT
    J Infect Dis; 1992 May; 165(5):805-12. PubMed ID: 1373751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of enzyme immunoassays for antibody to human T-lymphotropic viruses type I/II.
    Kline RL; Brothers T; Halsey N; Boulos R; Lairmore MD; Quinn TC
    Lancet; 1991 Jan; 337(8732):30-3. PubMed ID: 1670658
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serological confirmation of human T-lymphotropic virus type I infection in healthy blood and plasma donors.
    Anderson DW; Epstein JS; Lee TH; Lairmore MD; Saxinger C; Kalyanaraman VS; Slamon D; Parks W; Poiesz BJ; Pierik LT
    Blood; 1989 Nov; 74(7):2585-91. PubMed ID: 2804381
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Serological evaluation of human T lymphotropic virus type-I infection in routine hospital samples, especially using serodia.HTLV-I].
    Kamihira S; Nakashima S; Fukahori Y; Toriya K; Kanamura M; Ohta T
    Rinsho Byori; 1990 Jul; 38(7):783-8. PubMed ID: 2205742
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monoclonal antibodies and chemiluminescence immunoassay for detection of the surface protein of human T-cell lymphotropic virus.
    Papsidero LD; Dittmer RP; Vaickus L; Poiesz BJ
    J Clin Microbiol; 1992 Feb; 30(2):351-8. PubMed ID: 1371516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibody responses to the env epitopes of human T-lymphotropic virus type I in rhesus macaques' naturally infected with simian T-lymphotropic virus type I.
    Rudolph DL; Yee J; Palker T; Coligan JE; Lal RB
    Res Virol; 1993; 144(3):193-9. PubMed ID: 8395074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.